Clinical trial
Beta Cell Function Tests Over Time In Patients With T2dm Randomized To Metformin…
NCT00282945 · Pfizer, Industry · Terminated
Key facts
| NCT number | NCT00282945 |
|---|---|
| Title | Beta Cell Function Tests Over Time In Patients With T2dm Randomized To Metformin Or Rosiglitazone |
| Official title | Analyzing Beta Cell Function Tests Over Time In Patients With Type 2 Diabetes Mellitus Randomized To Metformin Or Rosiglitazone |
| Lead sponsor | Pfizer, Industry |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Type 2 Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | Rosiglitazone, Metformin |
| Enrollment | 29 |
| Start date | Jan 1, 2006 |
| Completion | Oct 1, 2007 |
| First posted | Jan 27, 2006 |
| Last update posted | Oct 13, 2008 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: